Contact information
Research groups
Mark Joy
Chief Statistician
Recent publications
-
A comparison of sodium-glucose co-transporter 2 inhibitor kidney outcome trial participants with a real-world chronic kidney disease primary care population
Forbes AK. et al, (2024), Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 40, 71 - 82
-
AZD1222 effectiveness against severe COVID-19 in individuals with comorbidity or frailty: The RAVEN cohort study
Meeraus W. et al, (2024), Journal of Infection, 88
-
Implementation of chronic kidney disease guidelines for sodium-glucose co-transporter-2 inhibitor use in primary care in the UK: a cross-sectional study
Forbes AK. et al, (2024), eClinicalMedicine, 68
-
Risk of severe COVID-19 outcomes after autumn 2022 COVID-19 booster vaccinations: a pooled analysis of national prospective cohort studies involving 7.4 million adults in England, Northern Ireland, Scotland and Wales
Bedston S. et al, (2024), The Lancet Regional Health - Europe, 37
-
Disparities in COVID-19 Mortality Amongst the Immunosuppressed: A Systematic Review and Meta-analysis for Enhanced Disease Surveillance.
Leston M. et al, (2024), J Infect